Wormhole, a cross-chain interoperability protocol, has processed over $70 billion in cumulative volume and more than one billion messages across 40 blockchains. This infrastructure enables seamless token transfers and multichain token issuance, attracting institutional users such as BlackRock, Apollo, and VanEck. Its Native Token Transfers (NTT) standard helps maintain token integrity across chains, solving liquidity fragmentation issues. Wormhole's strong security record and validator network have made it a trusted platform for tokenized assets, with plans to expand support to new blockchains like Cardano.
Wormhole's cross-chain protocol has processed over $70 billion in cumulative volume, illustrating significant institutional adoption. For readers following the broader cryptocurrency market, here is Pluang's market snapshot as of Sep 22, 2026 21:22 WIB: out of 50 major cryptocurrencies, 32 rose and 17 fell. Notable movers include VET at Rp164 with a 6.34% increase, XRP at Rp28,012 up 6.32%, and EGLD at Rp79,159 rising 6.01%.
MillerKnoll reported a strong Q1 2027 earnings per share (EPS) of $0.53, surpassing analyst expectations by over 51%, helped by tariff refunds and improved cost management. However, its revenue fell 3.4% year-over-year to $923.40 million, missing est...
THOR Industries reported Q4 earnings with an EPS of $0.78, missing analyst estimates and showing a 66.9% drop from last year. Despite this, the company beat revenue expectations with $2.31 billion, though revenue declined 8.4% year-over-year due to w...
Cracker Barrel Old Country Store is set to report its Q3 2026 earnings on September 23, with analysts predicting a significant decline. Earnings per share are expected to fall to $0.17 from $0.74 last year, and revenue is forecasted around $834.57 mi...
Mogotes Metals announced plans to significantly increase drilling at its Filo Sur project in Argentina and Chile to 20,000 meters starting November 2026, focusing on recent discoveries. It also aims to drill up to 50,000 meters at its Beskauga projec...
Viking Therapeutics surged 26.5% after releasing positive topline results from its GLP-1/GIP agonist VK2735 maintenance dosing study in adults with obesity. The data suggest multiple effective maintenance dosing schedules, potentially improving patie...
